Insights from 2023 ASH Annual Meeting


 

ASH 2023 Insights: "HR-QOL in Adults With Hemophilia B Treated With Fidanacogene Elaparvovec Gene Therapy"

34 views
January 16, 2024
Comments 0
Login to view comments. Click here to Login